HOUSTON: A treatment for leukaemia, nilotinib (Tasigna, Novartis), improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a Phase I clinical trial.

The researchers reported that the drug led to statistically significant and encouraging changes in toxic Read More »

CHICAGO: A potentially life-changing app for sufferers of dementia has been developed by four graduates.

Mind Mate is the brainchild of Mexican entrepreneur Rogelio Arellano who has worked with Patrick Renner, Susanne Mitschke and Gabriela Matic to build an interactive app that helps sufferers of Read More »

CHICAGO: A Canberra researcher has received more than $600,000 to fund dementia research in the nation’s capital and improve how aged care workers treat behavioural problems among residents with dementia.

Moyra Mortby from the ANU’s Centre for Research on Aging, Health and Wellbeing has collaborated Read More »

HOUSTON: There’s no shortage of research identifying the possible root causes of schizophrenia, but a new study published this week is the first to demonstrate that the brains of people with schizophrenia – or at risk of developing it – have significantly higher levels of Read More »